Nxt-ID, Inc. Announces Closing of Public Offering of

New Post Public Reply Private Reply Replies (0) Message Board
Jerseyfish

Nxt-ID, Inc. Announces Closing of Public Offering of Common Stock and Warrants
PR Newswire
NXT-ID, Inc. 33 minutes ago

SHELTON, Conn., Sept. 17, 2014 /PRNewswire/ -- Nxt-ID, Inc. (Nasdaq:NXTD and NXTDW) ("Nxt-ID" or the "Company" announced today that it has closed the previously announced underwritten public offering of its common stock and warrants. The Company offered 2,127,273 shares of common stock and 2,127,273 warrants to purchase shares of common stock, at a combined price to the public of $2.75 per share and related warrant. The warrants are exercisable for a period of five years beginning on today's date at an exercise price of $3.288 per share. Nxt-ID received gross proceeds from the offering, before deducting the underwriting discount and estimated offering expenses payable by Nxt-ID, of approximately $5,850,000.

The Company intends to use the net proceeds received from the offering for general corporate purposes including working capital, product development and marketing activities.

Northland Capital Markets and The Benchmark Company are acting as Co-Book-Running Managers, and Newport Coast Securities Inc. is acting as co-manager for the offering.

The offering was made pursuant to a registration statement on Form S-1 that Nxt-ID filed with the Securities and Exchange Commission ("SEC" and which is effective. A final prospectus supplement containing important information relating to these securities was filed with the SEC. Electronic copies of the prospectus supplement and accompanying prospectus will also be available on the website of the SEC at http://www.sec.gov. Copies of the final prospectus relating to the offering may be obtained from the offices of Northland Capital Markets, 45 South 7th Street, Suite 2000, Minneapolis, MN 55402, +1-612-460-4803, or from the above-mentioned SEC website.

This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Nxt-ID Technology

Nxt-ID's innovative MobileBio™ solution mitigates consumer risks associated with mobile computing, m-commerce and smart OS-enabled devices. The company is focused on the growing m-commerce market, launching its innovative MobileBio™ suite of biometric solutions that secure consumers' mobile platforms led by the Wocket™; a next generation smart wallet designed to replace all the cards in your wallet, no smart phone required. The Wocket works anywhere credit cards are accepted and only works with the user's biometric stamp of approval. www.wocketwallet.com.

NXT-ID's wholly owned subsidiary, 3D-ID LLC, is engaged in biometric identification and has 22 licensed patents in the field of 3D facial recognition http://www.nxt-id.com, http://3d-id.net.

For more information, please visit http://www.nxt-id.com.

Cautionary Statement Regarding Forward Looking Statements

Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company's expectations about its future operating results, performance and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words "anticipate," "believe," "estimate," "upcoming," "plan," "target", "intend" and "expect" and similar expressions, as they relate to Nxt-ID, Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company's actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.

Contact:

Corporate info: info@nxt-id.com
Investor Inquiries: Kirin Smith
ProActive Capital Group
Direct: +1-646-863-6519
ksmith@proactivecapital.com
Media: 800-665-0411
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sony Expands Versatile Wireless Headphone Lineup: 2026

Updated Category News Views 4

Renewed Focus on Sound: Sony's Latest Headphones Sony's dipping into the headphone market this time with a splash of style and sound signature updates. We've got the WH-1000XM4C, a next-gen version of the top-dog noise-cancelling cans, that are gonna catch the eye of every audiophile and traveler out there. WH-1000XM4C: The Flagship gets a Lift What they're offering is...

Continue Reading
GEEKOM A5 2027: Mini PC Built to Boost Your Game

Updated Category News Views 2

GEEKOM Raises the Bar with A5 2027 Build Every once in a blue moon, a piece of tech pricks up my ears and this time it's the GEEKOM A5 2027 Edition. Released on September 7, 2026, this contraption's not just joining the ranks—it's looking to redefine them. It's geared for the real-world junkie who’s raking through browser tabs, dropping into video meetings, and making...

Continue Reading
Lab Glassware Market Set for Steady Growth by 2031

Updated Category News Views 2

When you dive into the world of laboratory glassware, it might look like it's all pipettes and test tubes, but there's more bubbling under the surface. This market's got its eyes on a neat little climb from $7,630 million in 2026 to a forecasted $9,170 million by 2031. Ain't just speculation—this one's solid muscle growing at a comfortable 4.0% compound annual growth...

Continue Reading
WaFd and EverBank $3.9B Deal Spurs Big Bank Shift

Updated Category News Views 2

Remember the good old days when banking was just about collecting interest? Now it's all about combining forces to bolster strength, and that's just what we're seeing with WaFd, Inc. (NASDAQ: WAFD) and EverBank Financial Corp flipping the script and shaking hands on a $3.9 billion reverse merger. Strategic Vision: A New Chapter They're calling it a 'strategic...

Continue Reading
Hims & Hers Health Hit by FTC Claims and Class Action

Updated Category News Views 3

Hims Faces Harsh Lessons With FTC Lawsuit There's trouble brewing in the world of telehealth, and Hims & Hers Health (NYSE: HIMS) is right at the eye of the storm. They've gone from a darling of digital health to a pariah faster than you can say 'data breach.' On July 29, 2026, they took a hit so hard you’d think the company stepped into the ring with a heavyweight...

Continue Reading
CABP Market Sees Potential in New Treatments Rising

Updated Category News Views 2

Rising Threats and New Solutions in CABP Market Listen up, folks. The community-acquired bacterial pneumonia (CABP) market is set to swell. And why is that? Well, it's got everything to do with a growing disease burden, aging populations, and complications from comorbid conditions. But here's the kicker: antimicrobial resistance is climbing like a cat up a tree, and that...

Continue Reading
West Texas Weather Shapes Home Design Decisions

Updated Category News Views 2

West Texas Weather: A Tough Customer for Home Builders You'd think building a house is a straightforward gig, but slap it down in West Texas, and we're talking a whole different ballgame. With its brutal heat, howling winds, and wild temperature swings, Odessa isn't just painting by numbers. It's where Mother Nature is your uninvited consultant on every single...

Continue Reading
GBC 2026 Wraps Up: Korea Eyes Bio Industry Leadership

Updated Category News Views 3

GBC 2026: Korea's Giant Leap in Bio Innovation Well, there wasn't a dull moment at the 'Global Bio Conference 2026' in Seoul. Picture a melting pot where 5,600 participants from 19 countries converged to chat about the latest and greatest in biopharma innovation and regulatory strategies. That's not a setup you see every day, mind you. This event packed the room with...

Continue Reading
Dentsply Sirona Faces Insider Troubles: An Investor Call

Updated Category News Views 3

Are Dentsply Sirona Insiders on Thin Ice? The stock market's a tumultuous sea, and right now, it seems like some of those at the helm of Dentsply Sirona Inc. might be rocking the boat a bit too much. Let me tell you, navigating these corporate storms isn't for the faint-hearted. The latest noise coming from Halper Sadeh LLC suggests that some directors and officers over...

Continue Reading
DoorDash Speeds Up Gifting: Same-Day Delivery Wins

Updated Category News Views 1

Transforming Urgent Gift-Giving with Local Delivery Ever found yourself scrambling for a last-minute gift when time seems to be slipping away? That's where DoorDash steps up, changing the game with their same-day delivery options. In the fast-paced world we're living in, folks aren't just leaning on DoorDash for takeout anymore. They're pushing it as a lifeline for...

Continue Reading

Top 5 Most Recently Viewed Articles

Discovering Unique Luxury with The Edge List 2025 Highlights

Updated Category News Views 525

Celebrating The Edge List 2025 Forbes Travel Guide has unveiled The Edge List 2025, a captivating selection of luxury hotels, resorts, and cruises that redefine the essence of travel. This prestigious list honors properties that provide remarkable access to secluded and breathtaking destinations, paired with unparalleled comfort and extraordinary experiences. Exploring...

Continue Reading
NATURE Trial Success: enVast Cuts STEMI Infarct Size

Updated Category News Views 72

A New Angle on STEMI Treatment Who would've thought? In the crowded world of cardiovascular treatments, Vesalio just threw their hat into the ring with the enVast Coronary Clot Retriever. This gizmo's making waves after the NATURE trial results came down the pipeline. Dubbed a game-changer, it's shaking up how we tackle hefty thrombus burdens in STEMI patients. If you're...

Continue Reading
Aptose Biosciences Appoints New Auditor Amid Changes

Updated Category News Views 151

Aptose Biosciences Announces Transition in Auditing Firm In a significant move, Aptose Biosciences Inc. (TSX:APS), a clinical-stage precision oncology entity, has revealed that KPMG LLP will not be seeking re-appointment for the upcoming annual audit cycle. This announcement serves as a key development for the company as they progress towards enhancing their financial...

Continue Reading
Liquidity Withdrawal Sparks Crisis for LIBRA Token Investors

Updated Category News Views 250

Liquidity Withdrawal Crisis for LIBRA Token The LIBRA token has been at the center of turmoil after a massive liquidity removal estimated at $99 million, executed by parties connected to its creator, has come to light. This move has left many investors devastated and questioning the integrity of the project. Details of the Liquidity Withdrawal According to a recent...

Continue Reading
UNITS Moving and Portable Storage Earns Esteemed Industry Recognition

Updated Category News Views 110

UNITS Moving and Portable Storage Achieves Top Ranking Newsweek Reader's Choice Poll Showcases Brand's Reliability and Ease of Use UNITS® Moving and Portable Storage proudly announces its recognition as the second-best moving container company in a recent industry poll. This accolade reflects the positive feedback from customers nationwide who trust UNITS for their...

Continue Reading